Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Align Technology, Inc. - Common Stock (NQ: ALGN )

165.73 +5.22 (+3.25%)
Streaming Delayed Price Updated: 3:46 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Align Technology, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
10 Biggest Price Target Changes For Friday
Oppenheimer boosted Visa Inc. (NYSE:V) price target fr... 
Via Benzinga
Baidu And Nvidia Lead The QQQ Lower Thursday
U.S. indices were trading lower Thursday amid concerns the economic recovery is slowing. Growing concerns over the COVID-19 Delta variant have also... 
Via Benzinga
Exposures COVID-19
Where Align Tech Stands With Analysts
Align Tech (NASDAQ:ALGN) has observed the following analys... 
Via Benzinga
What 7 Analyst Ratings Have To Say About Align Tech
Analysts have provided the following ratings for Align Tech (NASDAQ: 
Via Benzinga
Netflix And Amazon Lead The Nasdaq Higher Tuesday
U.S. Indices continued higher Tuesday as the market rebounds from last week's weakness following a shift in the Fed's policy. ... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2021
Upgrades For FB Financial Corp (NYSE: 
Via Benzinga
3 Discounted MedTech Stocks Poised for Sturdy Growth in 2021
The COVID-19 pandemic caused significant financial chaos through 2020. 
Via Talk Markets
Exposures COVID-19
Intuitive Surgical Leads A Breakout Bonanza As Danaher, Omnicell Top Buy Points
Health care stocks Intuitive Surgical and Danaher broke out on Monday, as Omnicell and Globus Medical flirted with buy points. 
Via Investor's Business Daily
Repligen Joins Elite List Of Stocks With 95-Plus Composite Rating
The new score means Repligen is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria. 
Via Investor's Business Daily
Exposures COVID-19
When This Company Reports Earnings, We’ll Win No Matter How It Goes
Coming up next month, we’re about to have a golden opportunity to see a key aspect of my investing philosophy in action. Just because Wall Street might panic after catching a scrap of bad news doesn’t... 
Via Talk Markets
Medical Device Maker Quanterix Stock Shows Rising Relative Strength
On Friday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating upgrading to 91 from 88 a day before. 
Via Investor's Business Daily
3 Overlooked Healthcare Stocks to Buy Right Now
You definitely don't want to overlook their growth prospects. 
Via The Motley Fool
The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts
People will be getting back to their regular routines when it comes to medical and dental care. 
Via The Motley Fool
Exposures COVID-19
Hagens Berman: Invisalign Lawsuit Says Consumers Overpaid for Dental Aligners Due to Scheme by Align
From Hagens Berman Sobol Shapiro LLP
Via Business Wire
P/E Ratio Insights for Align Tech
In the current session, Align Tech Inc. (NASDAQ:ALGN) is trading at $626.27, after a 2.11% increase. Over the past month, the stock increased by 14.90%, and in the past... 
Via Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
Gainers Galera Therapeutics, Inc. (NASDAQ: GRTX) rose 39.6% to $9.23 in pre-market trading after the company disclosed updated data from its randomized, multicenter, placebo-... 
Via Benzinga
Align Technology Gives Investors Something to Smile About With Its Record Q1 Results
There was a lot to like with the orthodontic device maker's latest quarterly performance. 
Via The Motley Fool
Align Technology Inc (ALGN) Q1 2021 Earnings Call Transcript
ALGN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
13 Stocks Moving In Wednesday's After-Hours Session
Gainers Facebook (NASDAQ: FB) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also reported average daily... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Galera Therapeutics (NASDAQ:GRTX) stock moved upwards by 23.75% to $8.18 during Wednesday's after-market session. Today's trading volume for this security ended up... 
Via Benzinga
Align Technology Stock Creeps Toward Breakout On Sales, Earnings Beat
Align Technology on Wednesday reported adjusted earnings of $2.49 per share on $894.8 million in sales for its first quarter. ALGN stock popped. 
Via Investor's Business Daily
Recap: Align Tech Q1 Earnings
Shares of Align Tech (NASDAQ:ALGN) rose after the company reported Q1 results. Quarterly Results Earnings per share increased 241.10% year over year to $2.49, which beat the... 
Via Benzinga
Cramer Advises Viewers On Align Technology, Inseego And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't need Oscar Health Inc (NYSE: OSCR) because UnitedHealth Group Inc (NYSE: UNH) reported an... 
Via Benzinga
Medical Device STAAR Surgical Stock Trades Within Buying Range With Earnings On Deck
STAAR Surgical stock is trading near 128.33 buy point from a fourth-stage cup without handle that it cleared earlier. It's reporting earnings is on May 5. 
Via Investor's Business Daily
Three Medical Stocks To Watch, Including One With A Potential Breakout
Two have recent breakouts under their belts while a third is eyeing a fresh buy point. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2021
Upgrades Barclays upgraded the previous rating for SolarEdge Technologies Inc (NASDAQ:SEDG) from Equal-Weight to Overweight. In the fourth quarter, SolarEdge Technologies... 
Via Benzinga
Align Technology Nears Buy Point With Earnings Due
Align Technology is near a possible buy zone ahead of its next quarterly earnings report, expected on or around April 28. 
Via Investor's Business Daily
Cancer Therapy Novocure Stock Still On A High As It Clears Technical Benchmark
Cancer therapy Novocure stock had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. It's also an IBD 50 member. 
Via Investor's Business Daily
3 Top Value Stocks in Healthcare to Buy Right Now
Well-known guidance from Warren Buffett can help us identify opportunities in an expensive market. 
Via The Motley Fool
Cancer Therapy Novocure Stock Flashes Renewed Technical Strength
Novocure stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 67 to 92. 
Via Investor's Business Daily
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.